Methallylescaline
Methallylescaline (4-methylallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is also the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 40–65 mg and the duration is listed as 12–16 hours.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline.
Names | |
---|---|
IUPAC name
2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C14H21NO3 | |
Molar mass | 251.326 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Legal status
Allylescaline is illegal in Sweden as of 26 January 2016.[2]
gollark: Advertising.
gollark: Isn't that a misunderstanding of fiduciary duty? I vaguely remember reading that.
gollark: And apparently my hacky patch to the UI to make it not bad has broken now.
gollark: Ugh, Firefox wants me to "restart" it so it can "update".
gollark: I guess those are also WiFi devices now. But still.
See also
References
- Methallylescaline entry in PiHKAL
- "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.